Cargando…
Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer
BACKGROUND: The aim of this study was to examine the impact of the Charlson Comorbidity Index-Grade (CCI-G) on predicting outcomes and overall survival after open and minimally invasive esophagectomy (MIE). METHODS: One hundred and forty-six patients who underwent esophagectomy between 1995 and 2011...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102391/ https://www.ncbi.nlm.nih.gov/pubmed/23846365 http://dx.doi.org/10.1007/s00464-013-3066-5 |
_version_ | 1783511814043074560 |
---|---|
author | Dolan, James P. Kaur, Taranjeet Diggs, Brian S. Luna, Renato A. Schipper, Paul H. Tieu, Brandon H. Sheppard, Brett C. Hunter, John G. |
author_facet | Dolan, James P. Kaur, Taranjeet Diggs, Brian S. Luna, Renato A. Schipper, Paul H. Tieu, Brandon H. Sheppard, Brett C. Hunter, John G. |
author_sort | Dolan, James P. |
collection | PubMed |
description | BACKGROUND: The aim of this study was to examine the impact of the Charlson Comorbidity Index-Grade (CCI-G) on predicting outcomes and overall survival after open and minimally invasive esophagectomy (MIE). METHODS: One hundred and forty-six patients who underwent esophagectomy between 1995 and 2011 for stage II and III cancer were selected and separated into open esophagectomy (Open) and MIE groups. Risk adjustment was performed using the CCI-G. The outcomes of interest were operative time, estimated blood loss (EBL), lymph node harvest, length of hospital stay (LOS), major complications, 30-day mortality, and overall survival. RESULTS: Sixty-four patients (44 %) underwent Open while 71 (49 %) had MIE. An additional (7 %) were converted and classified with MIE. There was no significant difference between MIE and Open in terms of operative time. MIE had less EBL (mean difference = 234 mL, p < 0.001), higher lymph node harvest (mean = 7.4 nodes, p < 0.001), and shorter LOS (median = 1.5 days, p = 0.02). Atrial arrhythmias were the most frequent complication, occurring in 33 % of patients in both the MIE and the Open group (p = 0.988). Thirty-day mortality was 2 % for MIE and 5 % for Open (p = 0.459). Five-year survival was 41 % for MIE and 33 % for Open (p = 0.513). Operative approach, age, gender, BMI, clinical stage, and neoadjuvant therapy did not have any significant effect on the outcomes or overall survival. CCI-G influenced outcomes with operative time, LOS, cardiovascular complication, and anastomotic leak rate, favoring CCI-G 0 compared to CCI-G 3. Overall survival was worse for CCI-G 1 in comparison with CCI-G 0 [hazard ratio (HR) 1.99, p = 0.027]. CONCLUSIONS: MIE is a safe alternative to open esophagectomy for the treatment of locally advanced esophageal cancer. The presence of comorbidities increased operative time, length of hospital stay, and postoperative complications while worsening overall survival. |
format | Online Article Text |
id | pubmed-7102391 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-71023912020-03-31 Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer Dolan, James P. Kaur, Taranjeet Diggs, Brian S. Luna, Renato A. Schipper, Paul H. Tieu, Brandon H. Sheppard, Brett C. Hunter, John G. Surg Endosc Article BACKGROUND: The aim of this study was to examine the impact of the Charlson Comorbidity Index-Grade (CCI-G) on predicting outcomes and overall survival after open and minimally invasive esophagectomy (MIE). METHODS: One hundred and forty-six patients who underwent esophagectomy between 1995 and 2011 for stage II and III cancer were selected and separated into open esophagectomy (Open) and MIE groups. Risk adjustment was performed using the CCI-G. The outcomes of interest were operative time, estimated blood loss (EBL), lymph node harvest, length of hospital stay (LOS), major complications, 30-day mortality, and overall survival. RESULTS: Sixty-four patients (44 %) underwent Open while 71 (49 %) had MIE. An additional (7 %) were converted and classified with MIE. There was no significant difference between MIE and Open in terms of operative time. MIE had less EBL (mean difference = 234 mL, p < 0.001), higher lymph node harvest (mean = 7.4 nodes, p < 0.001), and shorter LOS (median = 1.5 days, p = 0.02). Atrial arrhythmias were the most frequent complication, occurring in 33 % of patients in both the MIE and the Open group (p = 0.988). Thirty-day mortality was 2 % for MIE and 5 % for Open (p = 0.459). Five-year survival was 41 % for MIE and 33 % for Open (p = 0.513). Operative approach, age, gender, BMI, clinical stage, and neoadjuvant therapy did not have any significant effect on the outcomes or overall survival. CCI-G influenced outcomes with operative time, LOS, cardiovascular complication, and anastomotic leak rate, favoring CCI-G 0 compared to CCI-G 3. Overall survival was worse for CCI-G 1 in comparison with CCI-G 0 [hazard ratio (HR) 1.99, p = 0.027]. CONCLUSIONS: MIE is a safe alternative to open esophagectomy for the treatment of locally advanced esophageal cancer. The presence of comorbidities increased operative time, length of hospital stay, and postoperative complications while worsening overall survival. Springer US 2013-07-12 2013 /pmc/articles/PMC7102391/ /pubmed/23846365 http://dx.doi.org/10.1007/s00464-013-3066-5 Text en © Springer Science+Business Media New York 2013 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Dolan, James P. Kaur, Taranjeet Diggs, Brian S. Luna, Renato A. Schipper, Paul H. Tieu, Brandon H. Sheppard, Brett C. Hunter, John G. Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer |
title | Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer |
title_full | Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer |
title_fullStr | Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer |
title_full_unstemmed | Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer |
title_short | Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer |
title_sort | impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102391/ https://www.ncbi.nlm.nih.gov/pubmed/23846365 http://dx.doi.org/10.1007/s00464-013-3066-5 |
work_keys_str_mv | AT dolanjamesp impactofcomorbidityonoutcomesandoverallsurvivalafteropenandminimallyinvasiveesophagectomyforlocallyadvancedesophagealcancer AT kaurtaranjeet impactofcomorbidityonoutcomesandoverallsurvivalafteropenandminimallyinvasiveesophagectomyforlocallyadvancedesophagealcancer AT diggsbrians impactofcomorbidityonoutcomesandoverallsurvivalafteropenandminimallyinvasiveesophagectomyforlocallyadvancedesophagealcancer AT lunarenatoa impactofcomorbidityonoutcomesandoverallsurvivalafteropenandminimallyinvasiveesophagectomyforlocallyadvancedesophagealcancer AT schipperpaulh impactofcomorbidityonoutcomesandoverallsurvivalafteropenandminimallyinvasiveesophagectomyforlocallyadvancedesophagealcancer AT tieubrandonh impactofcomorbidityonoutcomesandoverallsurvivalafteropenandminimallyinvasiveesophagectomyforlocallyadvancedesophagealcancer AT sheppardbrettc impactofcomorbidityonoutcomesandoverallsurvivalafteropenandminimallyinvasiveesophagectomyforlocallyadvancedesophagealcancer AT hunterjohng impactofcomorbidityonoutcomesandoverallsurvivalafteropenandminimallyinvasiveesophagectomyforlocallyadvancedesophagealcancer |